MedDevice Market Update, Q2 2026

• Corporate strategics are driving M&A to secure transformative scale, highlighted by Danaher's $9.9 billion acquisition of Masimo to capture advanced AI-enabled patient monitoring platforms.
• Venture funding surged to $3.8 billion in Q2, concentrating capital into high-growth, specialized segments such as robotic surgery, precision surgical instruments, and minimally invasive technologies.
• The acceleration of care migration into home-based settings is fueling rapid adoption of clinical wearables and at-home diagnostics, supported by expanding reimbursement and AI-driven real-world evidence.
• Heightened regulatory scrutiny under the FDA's new QMSR and persistent talent shortages are forcing MedDevice manufacturers to reshore supply chains and deploy predictive AI tools for operational resilience.

Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M -$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.

Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at [email protected].